Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does 99mTc-sestamibi uptake discriminate breast tumors?
Cayre A, Cachin F, Maublant J, Mestas D, Penault-Llorca F. Cayre A, et al. Among authors: mestas d. Cancer Invest. 2004;22(4):498-504. doi: 10.1081/cnv-200026388. Cancer Invest. 2004. PMID: 15565806
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N, D'Incan M, Bonafous J, Bacin F, Labarre P, Moreau MF, Mestas D, Noirault E, Chossat F, Berthommier E, Papon J, Bayle M, Souteyrand P, Madelmont JC, Veyre A. Moins N, et al. Among authors: mestas d. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1478-84. doi: 10.1007/s00259-002-0971-6. Epub 2002 Sep 11. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397467 Clinical Trial.
22 results